Holen Sie sich die Stockscreener-App
24.07
4.26%
-1.07
Schlusskurs vom Vortag:
$25.14
Offen:
$24.59
24-Stunden-Volumen:
421.42K
Relative Volume:
1.05
Marktkapitalisierung:
$1.15B
Einnahmen:
$151.91M
Nettoeinkommen (Verlust:
$-46.03M
KGV:
-23.83
EPS:
-1.01
Netto-Cashflow:
$5.65M
1W Leistung:
-7.17%
1M Leistung:
-12.98%
6M Leistung:
+9.16%
1J Leistung:
+11.18%
1-Tages-Spanne:
$23.96
$24.73
1-Wochen-Bereich:
$23.96
$26.68
52-Wochen-Spanne:
$19.10
$29.62
Biolife Solutions Inc Stock (BLFS) Company Profile
Firmenname
Biolife Solutions Inc
Sektor
Telefon
(425) 401-1400
Adresse
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Vergleichen Sie BLFS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
24.07 | 1.21B | 151.91M | -46.03M | 5.65M | -1.01 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2024-09-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-11 | Eingeleitet | Craig Hallum | Buy |
| 2022-04-25 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-10-19 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-05-14 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2021-03-23 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-18 | Eingeleitet | Cowen | Outperform |
| 2020-08-11 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-07-08 | Bestätigt | Maxim Group | Buy |
| 2020-02-24 | Eingeleitet | Lake Street | Buy |
| 2020-02-19 | Eingeleitet | The Benchmark Company | Buy |
| 2020-02-06 | Fortgesetzt | B. Riley FBR | Buy |
| 2020-01-08 | Eingeleitet | Stephens | Overweight |
| 2019-11-21 | Eingeleitet | Oppenheimer | Outperform |
| 2019-07-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-11-10 | Bestätigt | Maxim Group | Buy |
| 2017-09-19 | Bestätigt | Maxim Group | Buy |
| 2017-07-05 | Hochstufung | Janney | Neutral → Buy |
| 2017-03-10 | Bestätigt | Maxim Group | Buy |
| 2017-01-19 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Biolife Solutions Inc Aktie (BLFS) Neueste Nachrichten
How BioLife Solutions Inc. stock trades during market volatilityJuly 2025 Volume & Community Verified Trade Signals - newser.com
Is BioLife Solutions Inc. (BJX1) stock attractive for growth fundsJuly 2025 Earnings & Daily Stock Trend Reports - newser.com
Why BioLife Solutions Inc. (BJX1) stock stays on top picksWeekly Investment Report & Free Growth Oriented Trading Recommendations - newser.com
Will BioLife Solutions Inc. (BJX1) stock issue positive guidanceEarnings Growth Report & Safe Entry Zone Identification - newser.com
Visualizing BioLife Solutions Inc. stock with heatmapsTrend Reversal & Safe Investment Capital Preservation Plans - newser.com
BioLife Solutions CEO Makes a Major Stock Move - TipRanks
Insider Sell: Greef De Sells 100,000 Shares of BioLife Solutions Inc (BLFS) - GuruFocus
Biolife Solutions Insider Sold Shares Worth $2,580,422, According to a Recent SEC Filing - MarketScreener
Will BioLife Solutions Inc. outperform the marketTrade Signal Summary & High Accuracy Trade Alerts - newser.com
How institutional buying supports BioLife Solutions Inc. stockJuly 2025 Highlights & Entry Point Confirmation Signals - newser.com
Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), BioLife Solutions (BLFS) and Cardiff Oncology (CRDF) - The Globe and Mail
Published on: 2025-11-12 09:13:42 - newser.com
BioLife Solutions raises 2025 revenue guidance to $96M as cell processing momentum accelerates - MSN
Does BioLife Solutions Inc. qualify in momentum factor screeningTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
What to do if you’re stuck in BioLife Solutions Inc.Fed Meeting & Advanced Technical Analysis Signals - newser.com
BioLife Solutions (BLFS) Refocuses on Cell Processing After Evo Sale—Is Its Core Platform Ready to Scale? - simplywall.st
BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2025 Earnings Call Transcript - Insider Monkey
Why BioLife Solutions (BLFS) Is Up After Raising 2025 Guidance and Sharpening Its Cell Processing Focus - Yahoo Finance
BioLife Solutions, Inc. (BLFS) Surpasses Q3 Earnings and Revenue Estimates - MSN
BioLife Solutions Reports Strong Q3 Earnings Growth - TipRanks
Using R and stats models for BioLife Solutions Inc. forecastingJuly 2025 Snapshot & Entry and Exit Point Strategies - newser.com
Will BioLife Solutions Inc. (BJX1) stock maintain strong growthOil Prices & Reliable Entry Point Trade Alerts - newser.com
BioLife Solutions Inc (BLFS) Q3 2025 Earnings Call Highlights: S - GuruFocus
BioLife Solutions Doubles Down On Cell Processing Profits - Finimize
BioLife Solutions Inc (BLFS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
BioLife Solutions: Strong Financial Performance and Strategic Focus Justify Buy Rating - TipRanks
Finanzdaten der Biolife Solutions Inc-Aktie (BLFS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.23%
0.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):